COMMUNIQUÉS West-GlobeNewswire

Precision Optics Reports First Quarter Fiscal Year 2026 Financial Results
13/11/2025
Conference Call Scheduled for today, November 13, 2025, at 5:00pm ET GARDNER, Mass., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced [...]
Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December
13/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its [...]
Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio
13/11/2025
INSIDE INFORMATION REGULATED INFORMATION Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio Financings are comprised of equity investments, including from Cochlear, [...]
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
13/11/2025
KUALA LUMPUR, Malaysia, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Bio Green Med Solution, Inc. (NASDAQ: BGMS, NASDAQ: BGMSP; "BGMS" or the "Company" (formerly Cyclacel Pharmaceuticals, Inc.)), a diversified company engaged [...]
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
13/11/2025
Q3 2025 Revenue of $11.4 Million, an Increase of 17% over Q3 2024 83% Growth in Year-Over-Year Revenue for International Medical Cannabis International Medical sales now 56% of Total Revenue Increased Cash Balance of $ [...]
Cingulate Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
13/11/2025
Industry Veteran Bryan Downey Named Chief Commercial Officer NDA Accepted with May 2026 PDUFA Date Commercial Supply Agreement Executed KANSAS CITY, Kan., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING [...]
Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium)
13/11/2025
DURHAM, N.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today [...]
Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
13/11/2025
Successfully began trading on NASDAQ under ticker TTRX on October 8, 2025 Strengthened its Board of Directors with the appointments of Arthur Golden and Dr. Kent Kester Entered into a global supply, development, and [...]
MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial
13/11/2025
Publication of Interim Results and Presentation at Recent Industry Event Demonstrate Clinical Benefit Associated with Use of EPIEFFECT When Compared to Standard of Care (“SOC”) Publication Adds to Large Compendium of [...]
CytomX Therapeutics to Present at the Jefferies London Healthcare Conference
13/11/2025
SOUTH SAN FRANCISCO, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced that Sean McCarthy, D.Phil., [...]
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
13/11/2025
New funding brings total capital raised to $135 million Molecular gates offer the convenience of a pill with potential for superior efficacy through a novel mechanism that eliminates disease-causing proteins at their [...]
GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes
13/11/2025
GenoSafe étend son leadership en expertise analytique avec l’ouverture de nouveaux laboratoires aux standards internationaux pour soutenir la filière des thérapies innovantes Évry-Courcouronnes , le 13 novembre 2025 - [...]
GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector
13/11/2025
GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Évry-Courcouronnes , France, N ovemb er 16th , 2025 - GenoSafe, the [...]
Matisse Pharmaceuticals successfully completes study with prolonged infusion of M6229 in healthy volunteers
13/11/2025
Geleen, November 13 th , 2025. Matisse Pharmaceuticals B.V., a clinical stage company developing a medicinal product for the treatment of sepsis, today announced top line results from its phase 1 study evaluating the [...]
SCIENTURE Reports Q3 2025 Financial Results and Provides Business Update
13/11/2025
Reports Significant Revenue Growth to $590K and Substantial Increase in Gross Profit to $575K Launched Sales of Arbli ™ , the First FDA-Approved Ready-To-Use Liquid Formulation of Losartan for Hypertension COMMACK, NY, [...]
La MHRA approuve la demande d’essai clinique de BetaGlue Therapeutics pour YntraDose™ dans le traitement du cancer du pancréas localement avancé non résécable (uLA-PDAC)
13/11/2025
MILAN, 13 nov. 2025 (GLOBE NEWSWIRE) -- BetaGlue ® Therapeutics (« BetaGlue » ou la « Société »), une société d’oncologie en phase clinique développant une solution innovante de radiothérapie pour le traitement ciblé [...]
Biofrontera Inc. Reports Third Quarter 2025 Financial Results and Provides a Business Update
13/11/2025
Conference call will be held today, Thursday, November 13 at 10:00 am ET Woburn, MA, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the [...]
Nanox to Launch FDA-Cleared Nanox.ARC X and Present development of new AI innovations at RSNA 2025 Annual Meeting
13/11/2025
Live demonstrations of Nanox.ARC X to be featured at RSNA booth ( 3914, South Hall Level 3) every 30 minutes Innovation Theater p resentation to highlight development of pulmonary nodule AI solution, as future component [...]
Candel Therapeutics Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
13/11/2025
Presented new subgroup analyses from phase 3 clinical trial of CAN-2409 in localized prostate cancer at the American Society for Radiation Oncology (ASTRO) 2025 meeting, demonstrating improved prostate cancer-specific [...]

Pages